Miniaturized injectable and locally acting therapeutics

ASCIL Biopharm is a clinical-stage company focused on the research and development of advanced drug delivery systems, particularly emphasizing controlled-release formulations and precision medical devices. Their expertise includes creating controlled-release formulations for both systemic and locoregional delivery, which cater to high-dose and high-concentration needs. The company is also involved in the development of innovative precision medical devices designed for various injectable forms, including liquid, viscous, and solid products. Notable projects include the APOC | AQUE system, which enhances the bioavailability of somatostatin analogs for treating neuroendocrine tumors, and OnyMed, an innovative implant for antifungal treatment of nail diseases.

In addition to their R&D efforts, ASCIL Biopharm operates as a Contract Development and Manufacturing Organization (CDMO), offering formulation, analytics, and manufacturing services to support early-stage drug product development. Their portfolio features advanced devices such as the PlaiSir Control Injectors, which utilize rotation to manage injection force and enhance delivery stability, and the SelFill Micro Dispensers, designed for painless injections with precise dosing. The company also promotes collaboration through licensing and co-development partnerships, aiming to accelerate the development of drug delivery systems while providing expert services to meet the needs of their partners.

Spain

Ascil Biopharm is a Drug Delivery System company specialized in Long Acting Injectables (LAI) and devices. Our Research and development is focused in Controlled Release Formulations (CRF) and precision medical devices to enhance efficiency, safety, and patient convenience.

ASCIL Biopharm

Company Details